Heart failure & cardiomyopathies

Early Diuretic Response and Outcome Prediction in Ambulatory Worsening Heart Failure: Natriuresis Versus Diuresis

ESC Heart FailPublished post-hoc analysis of the SALT-HF trial

Authors' conclusion

In patients with ambulatory WHF treated with IV furosemide, 3-h urinary sodium predicted 30-day outcomes whereas 3-h diuresis did not.

Study context

Population
Patients with ambulatory worsening heart failure (WHF) randomized to receive intravenous furosemide with or without hypertonic saline solution
Participants
167 patients
Comparison
3-h urinary sodium (uNa+) vs 3-h urine output (diuresis) following intravenous (IV) diuretic infusion as predictors of 30-day adverse events

Primary result

As reported in the abstract

Composite endpoint:
  • Death
  • Heart failure hospitalization
  • The need for outpatient IV diuretics
· 30 days

Experienced the composite endpoint

50

29.9%

Further findings

AUC-ROC

OutcomeInverse of 3-h natriuresis3-h diuresisP value
AUC-ROC for 30-day adverse events0.6800.601P = 0.092
  • AUC-ROC for 30-day adverse events: trend towards a higher AUC-ROC for the inverse of 3-h natriuresis

Association of lower 3-h uNa+ with 30-day adverse events

Lower 3-h uNa+ associated with a higher risk of 30-day adverse events
P = 0.008
  • Multivariate analyses

Association of 3-h diuresis with 30-day adverse outcomes

3-h diuresis did not significantly predict 30-day adverse outcomes
P = 0.424
  • Multivariate analyses

Baseline characteristics

Median age
81 years
Male
69.5%
Patients with lower 3-h urinary sodium and diuresis were older and exhibited reduced kidney function and haemoglobin levels

Original publication

Early Diuretic Response and Outcome Prediction in Ambulatory Worsening Heart Failure: Natriuresis Versus Diuresis. ESC Heart Fail. Published 28 March 2025. doi:10.1002/ehf2.15275

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.